Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02588170 |
|---|---|
| Brief Title: | Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors |
| First Submitted : | October 26, 2015 |
| First Submitted that Met QC Criteria : | October 26, 2015 |
| First Posted : | October 27, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 29, 2023 |
| Last Update Posted : | March 30, 2023 |